*Soirindhri Banerjee1, Ishika Mahajan2, Aruni Ghose3,4,5,6,7, Stergios Boussios5,8,9,10, Shivam Chakraborty11
1Department of Radiation Oncology, Institute of Post Graduate Medical Education & Research and SSKM Hospital, Kolkata, India.
2Department of Haematology and Oncology, Lincoln County Hospital, United Lincolnshire Hospitals Trust, Lincoln LN2 5QY
3Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
4Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London, UK
5Department of Medical Oncology, Medway NHS Foundation Trust, Kent, UK
6United Kingdom and Ireland Global Cancer Network
7Immuno-Oncology Clinical Network, UK
8Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK
9Kent and Medway Medical School, University of Kent, Canterbury, UK
10AELIA Organisation, 9th Km Thessaloniki – Thermi, 57001, Thessaloniki, Greece
11Depatment of Pathology, Institute of Post Graduate Medical Education & Research and SSKM Hospital, Kolkata, India.
*Corresponding Author
Soirindhri Banerjee
Senior Resident
Department of Radiation Oncology, Institute of Post Graduate Medical Education & Research and SSKM Hospital.
244, A J C Bose Road, Kolkata 700020, India.
Email – soirindhribanerjee@yahoo.co.in